【レポートの概要(一部)】
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
• Market segmentation by product
• Comparison by product
• Targeted therapy – Market size and forecast 2018-2023
• Chemotherapy – Market size and forecast 2018-2023
• Immunotherapy – Market size and forecast 2018-2023
• Market opportunity by product
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2018-2023
• Europe – Market size and forecast 2018-2023
• Asia – Market size and forecast 2018-2023
• ROW – Market size and forecast 2018-2023
• Key leading countries
• Market opportunity
PART 09: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 10: MARKET TRENDS
• Emergence of pipeline molecules
• Development of diagnostic tests and predictive markers
• Increasing research in regenerative medicines
PART 11: VENDOR LANDSCAPE
• Overview
• Landscape disruption
PART 12: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Boehringer Ingelheim International GmbH
• Bristol-Myers Squibb Co.
• F. Hoffmann-La Roche Ltd.
• Merck & Co. Inc.
• Mylan NV
• Novartis AG
• Otsuka Holdings Co. Ltd.
• Pfizer Inc.
• Takeda Pharmaceutical Co. Ltd.
• Teva Pharmaceutical Industries Ltd.
PART 13: APPENDIX
• Research methodology
• List of abbreviations
• Definition of market positioning of vendors
PART 14: EXPLORE TECHNAVIO
Exhibit 01: Vendors: Key offerings
Exhibit 02: Global pharmaceuticals market
Exhibit 03: Segments of global pharmaceuticals market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition – Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2018
Exhibit 18: Product – Market share 2018-2023 (%)
Exhibit 19: Comparison by product
Exhibit 20: Targeted therapy – Market size and forecast 2018-2023 ($ millions)
Exhibit 21: Targeted therapy – Year-over-year growth 2019-2023 (%)
Exhibit 22: Chemotherapy – Market size and forecast 2018-2023 ($ millions)
Exhibit 23: Chemotherapy – Year-over-year growth 2019-2023 (%)
Exhibit 24: Immunotherapy – Market size and forecast 2018-2023 ($ millions)
Exhibit 25: Immunotherapy – Year-over-year growth 2019-2023 (%)
Exhibit 26: Market opportunity by product
Exhibit 27: Customer landscape
Exhibit 28: Market share by geography 2018-2023 (%)
Exhibit 29: Geographic comparison
Exhibit 30: North America – Market size and forecast 2018-2023 ($ millions)
Exhibit 31: North America – Year-over-year growth 2019-2023 (%)
Exhibit 32: Top 3 countries in North America
Exhibit 33: Europe – Market size and forecast 2018-2023 ($ millions)
Exhibit 34: Europe – Year-over-year growth 2019-2023 (%)
Exhibit 35: Top 3 countries in Europe
Exhibit 36: Asia – Market size and forecast 2018-2023 ($ millions)
Exhibit 37: Asia – Year-over-year growth 2019-2023 (%)
Exhibit 38: Top 3 countries in Asia
Exhibit 39: ROW – Market size and forecast 2018-2023 ($ millions)
Exhibit 40: ROW – Year-over-year growth 2019-2023 (%)
Exhibit 41: Top 3 countries in ROW
Exhibit 42: Key leading countries
Exhibit 43: Market opportunity
Exhibit 44: Impact of drivers and challenges
Exhibit 45: Vendor landscape
Exhibit 46: Landscape disruption
Exhibit 47: Vendors covered
Exhibit 48: Vendor classification
Exhibit 49: Market positioning of vendors
Exhibit 50: Boehringer Ingelheim International GmbH – Vendor overview
Exhibit 51: Boehringer Ingelheim International GmbH – Product segments
Exhibit 52: Boehringer Ingelheim International GmbH – Organizational developments
Exhibit 53: Boehringer Ingelheim International GmbH – Geographic focus
Exhibit 54: Boehringer Ingelheim International GmbH – Segment focus
Exhibit 55: Boehringer Ingelheim International GmbH – Key offerings
Exhibit 56: Boehringer Ingelheim International GmbH – Key customers
Exhibit 57: Bristol-Myers Squibb Co. – Vendor overview
Exhibit 58: Bristol-Myers Squibb Co. – Product segments
Exhibit 59: Bristol-Myers Squibb Co. – Organizational developments
Exhibit 60: Bristol-Myers Squibb Co. – Geographic focus
Exhibit 61: Bristol-Myers Squibb Co. – Key offerings
Exhibit 62: Bristol-Myers Squibb Co. – Key customers
Exhibit 63: F. Hoffmann-La Roche Ltd. – Vendor overview
Exhibit 64: F. Hoffmann-La Roche Ltd. – Product segments
Exhibit 65: F. Hoffmann-La Roche Ltd. – Organizational developments
Exhibit 66: F. Hoffmann-La Roche Ltd. – Geographic focus
Exhibit 67: F. Hoffmann-La Roche Ltd. – Segment focus
Exhibit 68: F. Hoffmann-La Roche Ltd. – Key offerings
Exhibit 69: F. Hoffmann-La Roche Ltd. – Key customers
Exhibit 70: Merck & Co. Inc. – Vendor overview
Exhibit 71: Merck & Co. Inc. – Product segments
Exhibit 72: Merck & Co. Inc. – Organizational developments
Exhibit 73: Merck & Co. Inc. – Geographic focus
Exhibit 74: Merck & Co. Inc. – Segment focus
Exhibit 75: Merck & Co. Inc. – Key offerings
Exhibit 76: Merck & Co. Inc. – Key customers
Exhibit 77: Mylan NV – Vendor overview
Exhibit 78: Mylan NV – Product segments
Exhibit 79: Mylan NV – Organizational developments
Exhibit 80: Mylan NV – Geographic focus
Exhibit 81: Mylan NV – Segment focus
Exhibit 82: Mylan NV – Key offerings
Exhibit 83: Mylan NV – Key customers
Exhibit 84: Novartis AG – Vendor overview
Exhibit 85: Novartis AG – Product segments
Exhibit 86: Novartis AG – Organizational developments
Exhibit 87: Novartis AG – Geographic focus
Exhibit 88: Novartis AG – Segment focus
Exhibit 89: Novartis AG – Key offerings
Exhibit 90: Novartis AG – Key customers
Exhibit 91: Otsuka Holdings Co. Ltd. – Vendor overview
Exhibit 92: Otsuka Holdings Co. Ltd. – Product segments
Exhibit 93: Otsuka Holdings Co. Ltd. – Organizational developments
Exhibit 94: Otsuka Holdings Co. Ltd. – Geographic focus
Exhibit 95: Otsuka Holdings Co. Ltd. – Segment focus
Exhibit 96: Otsuka Holdings Co. Ltd. – Key offerings
Exhibit 97: Otsuka Holdings Co. Ltd. – Key customers
Exhibit 98: Pfizer Inc. – Vendor overview
Exhibit 99: Pfizer Inc. – Product segments
Exhibit 100: Pfizer Inc. – Organizational developments
Exhibit 101: Pfizer Inc. – Geographic focus
Exhibit 102: Pfizer Inc. – Segment focus
Exhibit 103: Pfizer Inc. – Key offerings
Exhibit 104: Pfizer Inc. – Key customers
Exhibit 105: Takeda Pharmaceutical Co. Ltd. – Vendor overview
Exhibit 106: Takeda Pharmaceutical Co. Ltd. – Product segments
Exhibit 107: Takeda Pharmaceutical Co. Ltd. – Organizational developments
Exhibit 108: Takeda Pharmaceutical Co. Ltd. – Geographic focus
Exhibit 109: Takeda Pharmaceutical Co. Ltd. – Key offerings
Exhibit 110: Takeda Pharmaceutical Co. Ltd. – Key customers
Exhibit 111: Teva Pharmaceutical Industries Ltd. – Vendor overview
Exhibit 112: Teva Pharmaceutical Industries Ltd. – Product segments
Exhibit 113: Teva Pharmaceutical Industries Ltd. – Organizational developments
Exhibit 114: Teva Pharmaceutical Industries Ltd. – Segment focus
Exhibit 115 Teva Pharmaceutical Industries Ltd. – Key offerings
Exhibit 116: Teva Pharmaceutical Industries Ltd. – Key customers
Exhibit 117: Validation techniques employed for market sizing
Exhibit 118: Definition of market positioning of vendors
【レポート販売概要】
■ タイトル:慢性骨髄性白血病治療法の世界市場2019-2023■ 英文:Chronic Myelogenous Leukemia Therapeutics Market by Product and Geography - Global Forecast and Analysis 2019-2023
■ 発行日:2019年8月28日
■ 調査会社:Technavio
■ 商品コード:IRTNTR31940
■ 調査対象地域:グローバル、アジア太平洋、ヨーロッパ、北米、その他
- テレラジオロジーの世界市場:イメージング技術別(X線、コンピューター断層撮影(CT)、超音波、磁気共鳴イメージング(MRI)、核イメージング、蛍光透視法、マンモグラフィー、その他)、技術別(ハードウェア、ソフトウェア、通信・ネットワーク)、エンドユーザー別(病院、外来手術センター、診断センター、その他)The global teleradiology market accounted for $2,709 million in 2017 and is expected to reach $10,621 million by 2025, at a CAGR of 18.4% from 2018 to 2025. Teleradiology is a service that has medical images construed by a radiologist from a distant location. These interpretations are made through several imaging techniques including CT, MRI, ultrasound, nuclear medicine, X-rays, and others, and h …
- 産業用コネクタの世界市場:工作機械用/産業自動化用/エネルギー産業用/土木用コネクタAbout Industrial Connectors A connector is a device that carries electrical power or electronic signals and connects an input or output part of an electronic or electrical device to the internal controls of a machine or another device. Connectors are an important factor to be considered in the initial set up of any industry. The use of cheap or low-grade connectors could result in degraded signals …
- 木材用接着剤及びバインダーの世界市場2015-2019About Wood Adhesives and Binders Wood adhesives and binders are used to bind together wood surfaces to create panels. They have high bond strength, durability, and temperature and chemical resistance, which provides customers with cost-effective solutions. They are used for various industrial and consumer applications such as in flooring, furniture and subcomponents, windows and doors, and cabinet …
- 世界のクラウド・ソフトウェア・サービス市場動向(2012-2016)TechNavio's analysts forecast the Global Cloud Software Services market to grow at a CAGR of 24.02 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing demand for cloud services. The Global Cloud Software Services market has also been witnessing the emergence of customized cloud services. However, issues relating to the security of cloud se …
- Remicade(クローン病治療薬):市場予測及び分析(~2022)Remicade (Crohn’s Disease) - Forecast and Market Analysis to 2022 Summary The Crohn’s disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon. These compounds will challenge the current biologics in an attempt to dislodge the stronghold of the TNF inhibitors, as they aim to tap into the lucrative portion of the CD therapeutics market. If their promising safety a …
- 水耕栽培の世界市場:用途別(屋内農業、屋外農業)、コンポーネント別(灌漑コンポーネント、照明、センサー、空調、建築材料、その他)The global aeroponics market size was valued at $578.70 million in 2018, and is projected to reach $3.53 billion by 2026, growing at a CAGR of 25.60% from 2019 to 2026. Aeroponics is an indoor gardening practice in which plants are grown and nourished by suspending their root structures in air. The process requires regular spraying of nutrients in a water solution. Aeroponics offers an efficient m …
- Lexapro (大うつ病性障害):医薬品市場予測及び分析(~2023)Lexapro (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded and competitive market, with more than 30 marketed products available for the treatment of patients with MDD. The depression market is about to enter a dynamic phase with imminent patent expiries for …
- ナノセルロースの世界市場2015Bio-based, renewable, not that expensive, easy to degrade, nanocellulose has good prospecnt in the market. It can find applications in many industrial spheres: paint and paper industry, pharmaceuticals, cosmetics, food, and many others. Despite the fact that nanocellulose has been developing in laboratories for a long time, it was scaled to commercial production only a few years ago. In 2011, Innv …
- ジカウイルス用ワクチンの世界市場機会分析Zika virus (ZIKV) is a member of the Flaviviridae family that includes several mosquito-borne viruses of major clinical importance, including yellow fever virus, Japanese encephalitis virus and dengue virus. Although widely distributed across West and East Africa and Southeast Asia (46 countries/territories since 2007), ZIKV has only recently been identified as a major cause of disease. In most ca …
- 世界の石油スルホン酸ナトリウム市場2015The Global Sodium Petroleum Sulfonate Industry Report 2015 is a professional and in-depth study on the current state of the Sodium Petroleum Sulfonate industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Sodium Petroleum Sulfonate market analysis is provided for the international markets including deve …
- 世界のマウスモデル市場動向及び予測(~2018):タイプ別(近交系、ノックアウト、条件付け)、技術別(マイクロインジェクション、胚性幹細胞)、疾患別(腫瘍学、免疫学、CNS)、サービス別(繁殖、冷凍保存、検疫)、ケア製品別(カゴ、寝床、餌)The global mice model market is segmented on the basis of type, technology, disease, and mice model services. By type, the market comprises of inbred, outbred, knockout, conditioned/surgically modified, hybrid/congenic, and spontaneous mutant mice. The market for mice model services is segmented into breeding, cryopreservation, quarantine, rederivation, genetic testing, model in-licensing, and oth …
- 欧州の風力発電産業分析:Analyzing the European Wind Power IndustryAs demand on finite petroleum reserves and the price of the fuels derived from them continues to rise, renewable forms of energy are becoming more cost-effective and profitable. In the forefront of this renewable revolution is harnessing the sustainable power of wind. Today it is one of the most positive developments created by the present storm of uncertainty unleashed as a result of escalating o …
- グローバル小売市場におけるトップ10企業分析Synopsis The Conlumino Global Top 10 Retail Companies: Company Guide is a crucial resource for anyone looking to gain information on the top companies in the global retailers industry. Detailed company profile and SWOT analysis information is provided for all the leading companies who are ranked in order by total annual revenues generated. Wal-Mart Stores, Inc. Costco Wholesale Corporation Tesco P …
- 世界の国土安全保障及び緊急危機管理市場This report presents a complete analysis of the global homeland security market across the next five years. It analyses about the factors driving the market, the challenges faced by the industry and about the factors restraining the growth of the market. It also discusses the key industry trends, market trends and technology trends that is about to influence the global homeland security market. It …
- MISC Berhad:石油・ガスバリューチェーン分析レポート2013MISC Berhad Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "MISC Berhad" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “MISC Berhad”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report examines the company’s business …